Department of Biochemistry

Novel drugs have potential for treating tuberculosis

Drug-resistant tuberculosis is on the rise, and novel antibacterial drugs called SPTs have potential for treating the deadly lung infection.

Discussing cryo-EM

Yifan Chang, PhD, recently spoke about his team’s research using single particle cryo-EM (cryogenic electron microscopy) to study INO80, an ATP-dependent chromatin remodeling complex.

Cardiovascular research pioneer Inagami mourned

Tadashi Inagami, PhD, DSc, Vanderbilt University Professor of Biochemistry, emeritus, who helped characterize the biochemical basis for hypertension, heart failure and vascular disease, died in Pittsburgh, Pennsylvania, March 13 after a brief illness. He was 92.

Discovery lecture features electron microscopy leader Cheng

Yifan Cheng, PhD, a leader in electron microscopy technology development and structural studies of biological macromolecules, will deliver the next Discovery Lecture on Thursday, March 9.

Study explores new urinary tract infection treatment

Vanderbilt’s Neil Osheroff, PhD, is part of an international research collaboration resulting in what is on track to be the first new antibiotic treatment for uncomplicated urinary tract infections in more than 20 years.

Pending COVID-19 samples are prepared for testing in the Diagnostic Laboratories at VUMC.

Event to spotlight VUMC’s COVID-19 research efforts

The public is invited to listen in as scientists on the forefront of COVID-19 research at Vanderbilt University Medical Center share their personal stories on Wednesday afternoon, Nov. 16, in 214 Light Hall.

1 2 3 4 15